Analytical Data
-
Gene name
MUC3
- Application
-
Alternative Names
MUC3；MUC3；Mucin-3A
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q02505
-
Expression Region
全长
-
AA Sequence
full
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MUC3 is a member of the mucin family, comprising high molecular weight glycoproteins that play vital roles in protecting epithelial surfaces and modulating immune responses. These proteins are characterized by their extensive glycosylation, which is crucial for their functionality in epithelial tissue. Research on MUC3 has gained momentum due to its potential implications in various diseases, particularly cancer and inflammatory conditions. Abnormal expression or alterations in MUC3 have been associated with tumor progression, making it a target for therapeutic interventions. Additionally, investigations into the use of recombinant MUC3 proteins aim to explore their applications in vaccine development and drug delivery systems. The ability to produce MUC3 as a recombinant protein facilitates the study of its structural and functional properties, enabling researchers to better understand its role in pathophysiology. This research not only enhances our knowledge of MUC3's biological functions but also opens avenues for innovative treatments that leverage its unique characteristics, aiming to improve patient outcomes in disease management. The biotechnological advances in recombinant protein production provide a promising platform for further exploration of MUC3, paving the way for new diagnostic and therapeutic strategies in precision medicine.
